A Iliadis
Overview
Explore the profile of A Iliadis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdalaziz H, Bates P, Iliadis A, Vris A
Ann R Coll Surg Engl
. 2022 Jan;
104(1):74-75.
PMID: 34972495
No abstract available.
2.
Natsis K, Boura E, Kyriazis O, Iliadis A, Syntila S, Kostopoulos I, et al.
Neuroophthalmology
. 2016 Dec;
40(5):247-250.
PMID: 27928415
Bilateral internuclear ophthalmoplegia has been linked with various pathological conditions of the central nervous system (CNS), such as multiple sclerosis, stroke, tumours, and brainstem inflammatory processes. Herein the authors report...
3.
Chatzizisis Y, Ziakas A, Feloukidis C, Paramythiotis D, Hadjimiltiades S, Iliadis A, et al.
Herz
. 2013 Mar;
39(1):156-60.
PMID: 23483222
Pheochromocytoma is a catecholamine-secreting tumor of the adrenal glands whose typical presentation includes the triad of headache, palpitations, and diaphoresis. Pheochromocytoma crisis is an urgent medical condition whose diagnosis and...
4.
Faivre C, Barbolosi D, Iliadis A
Curr Top Med Chem
. 2012 Sep;
12(15):1660-4.
PMID: 22978337
The primary goal of phase I studies in oncology is to determine the MTD (Maximum Tolerated Dose) for a drug. This MTD is determined with respect to an accepted risk...
5.
Frances N, Claret L, Bruno R, Iliadis A
Cancer Chemother Pharmacol
. 2011 Apr;
68(6):1413-9.
PMID: 21476101
Purpose: Most of the cancer chemotherapy treatments employ drugs in combination. For combination treatments, it is relevant to assess interaction between two or more anticancer agents used in clinics. Based...
6.
Meille C, Iliadis A, Barbolosi D, Frances N, Freyer G
J Pharmacokinet Pharmacodyn
. 2008 Dec;
35(6):619-33.
PMID: 19107581
When modeling is required to describe pharmacokinetics and pharmacodynamics simultaneously, it is difficult to link time-concentration profiles and drug effects. When patients are under chemotherapy, despite the huge amount of...
7.
Meille C, Gentet J, Barbolosi D, Andre N, Doz F, Iliadis A
Clin Pharmacol Ther
. 2007 Oct;
83(6):873-81.
PMID: 17957185
Assessment of the maximum tolerated dose for a small sample of patients is the objective of phase I trials in oncology. We propose a new adaptive approach performing differentiation of...
8.
Katsinelos P, Pilpilids I, Paroutoglou G, Tsolkas P, Kotakidou R, Panagiotopoulou K, et al.
Surg Endosc
. 2004 Apr;
18(2):347.
PMID: 15106628
Tumors of the papillary region are an unusual and heterogeneous group of neoplasms that arise from the major papilla, the ampulla of Vater, and the peripapillary duodenum. Benign adenomas of...
9.
Katsinelos P, Paroutoglou G, Beltsis A, Tsolkas P, Arvaniti M, Katsiba D, et al.
Surg Endosc
. 2003 Nov;
18(1):165-6.
PMID: 14625765
Endoscopic retrograde cholangiopancreatography with biliary drainage is an effective therapeutic tool in the management of bile duct injuries associated with laparoscopic cholecystectomy. Placement of a stent or a nasobiliary drain...
10.
Katsinelos P, Paroutoglou G, Pilpilidis I, Tsolkas P, Papagiannis A, Kapelidis P, et al.
Surg Endosc
. 2003 Jun;
17(8):1324.
PMID: 12799880
Dieulafoy's lesion is an uncommon cause of major gastrointestinal bleeding and may be difficult to recognize. It consists of an arteriole that protrudes through a tiny mucosal defect usually within...